Biocad discussing potential Covid-19 vaccine production in China
Biocad is gearing up to produce 4-5 million doses per month of the VSV-based vaccine by the end of this year, if early-stage trials prove it to be safe and effective
Biocad is gearing up to produce 4-5 million doses per month of the VSV-based vaccine by the end of this year, if early-stage trials prove it to be safe and effective